| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.5 / 5 (155 reviews) | Tel Aviv, Israel | 41+ years34,000+ treatments | Biological therapy, Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, CAR T-cell therapy, Sarcoma Immunotherapy | Advanced or metastatic cancers | Offers a wide range of immunotherapy options, including CAR T-cell therapy and Keytruda. JCI accredited with a 90% success rate in cancer treatment. Research-focused team with access to clinical trials. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek | ||
| #2 | 4.4 / 5 (13 reviews) | Tel Aviv, Israel | 92,000+ treatments | Biological therapy, BCG therapy, Immunotherapy with Keytruda (Pembrolizumab), Immunotherapy for prostate cancer | Advanced melanoma and prostate cancer | Professor Yakov Shechter leads the Ella Lemelbaum Institute of Immuno-Oncology, specializing in innovative immunotherapies. Clinic uses modern TIL-cell therapy and participates in clinical trials for immunotherapy advancements. | Joint Commission International | ||
| #3 | 5.0 / 5 (0 reviews) | Tel Aviv, Israel | — | — | Immunotherapy | — | — | — |